EBIT: Income before interest and taxes.
Immunocore Holdings PLC Sponsored ADR (IMCR) had EBIT of $-45.35M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$400.02M |
|
$-35.51M |
|
$5.09M |
|
$394.93M |
|
$445.37M |
|
$-45.35M |
|
$26.25M |
|
$-19.10M |
|
$-19.10M |
|
$-35.51M |
|
$-35.51M |
|
$-35.51M |
|
$-35.51M |
|
|
EBIT |
$-45.35M |
$-42.09M |
|
50.35M |
|
50.35M |
|
$-0.71 |
|
$-0.71 |
|
| Balance Sheet Financials | |
$996.74M |
|
$11.46M |
|
$70.53M |
|
$1.07B |
|
$246.70M |
|
$393.12M |
|
$439.54M |
|
$686.24M |
|
$381.03M |
|
$381.03M |
|
$381.03M |
|
50.69M |
|
| Cash Flow Statement Financials | |
$-10.71M |
|
$-16.34M |
|
$12.37M |
|
$455.73M |
|
$467.71M |
|
$11.98M |
|
$37.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.04 |
|
-- |
|
-- |
|
0.51 |
|
1.03 |
|
98.73% |
|
-11.34% |
|
-11.34% |
|
-10.52% |
|
-4.77% |
|
-8.88% |
|
$-15.05M |
|
-- |
|
-- |
|
-- |
|
0.37 |
|
0.75 |
|
5.28 |
|
69.16 |
|
-9.32% |
|
-9.32% |
|
-3.33% |
|
-4.59% |
|
$7.52 |
|
$-0.30 |
|
$-0.21 |
|